Skip to main content
. 2017 Jun 20;16(2):1927–1945. doi: 10.3892/mmr.2017.6822

Table III.

Characteristics of subjects included in the meta-analysis of inteleukin-4 rs2070874 polymorphism and cancer risk.

Case Control


First author, year Country Ethnicity Cancer type n Genotypes CC/CT/TT Alleles C/T (%) n Genotypes CC/CT/TT Alleles C/T (%) P-value HWE NOS score (Ref.)
Amirzargar, 2005 Iran Caucasian Leukemia 30 20/5/5 75.0/25.0 40 22/18/0 77.5/22.5 0.066 7 (42)
Chang, 2015 Taiwan Asian Lung cancer 358 238/101/19 80.6/19.4 716 453/223/40 78.8/21.2 0.075 7 (35)
Crusius, 2008 Netherlands Caucasian Gastric cancer 243 159/77/7 81.3/18.7 1160 839/296/25 85.1/14.9 0.853 8 (11)
Gaur, 2011 India Caucasian Oral carcinoma 140 20/61/59 36.1/63.9 120 11/38/71 25.0/75.0 0.088 8 (28)
Gu, 2008 USA Mixed Skin cancer 217 160/52/5 85.7/14.3 214 165/43/6 87.1/12.9 0.132 8 (45)
Lu, 2010 China Asian Gastric cancer 1042 27/271/744 15.6/84.4 1099 24/332/743 17.3/82.7 0.062 7 (44)
Lu, 2014 China Asian Hepatocellular cancer 135 8/43/84 21.9/78.1 147 4/45/98 18.0/82.0 0.664 7 (31)
Purdue, 2007 USA Mixed Testicular germ cell tumor 501 364/128/9 85.4/14.6 598 447/139/12 86.4/13.6 0.757 8 (40)
Schonfeld, 2010 USA Mixed Breast cancer 818 600/206/12 85.9/14.1 1081 763/288/30 83.9/16.1 0.654 7 (21)
Shamran, 2014 Iraq Caucasian Brain tumor 100 71/26/3 84.0/16.0 40 22/13/5 71.3/28.7 0.191 8 (43)
Wiemels, 2007 USA Mixed Brain tumor 386 281/93/12 84.8/15.2 471 328/134/9 83.9/16.1 0.267 8 (39)

Significant associations are denoted in bold font. HWE, Hardy-Weinberg equilibrium; NOS, Newcastle-Ottawa quality assessment scale.